UK Government Updates Smoking Cessation Guidelines for Doctors, Recognizes E-Cigarettes as Effective Aid

Apr.12.2022
A new smoking cessation guide for doctors in the UK emphasizes the potential harm reduction and quitting potential of e-cigarettes.

The UK government website has announced that the Office for Health Improvement and Disparities has released an updated quit smoking guide for doctors, highlighting the harm reduction and potential for quitting smoking with the aid of e-cigarettes in the section on smoking cessation aids.

 

It has been reported that currently 52.7% of smokers in the UK want to quit, but relying solely on willpower results in a low success rate. Therefore, professional guidance from doctors is crucial in assisting smokers to effectively use quitting aids and significantly improve their chances of success.

 

It is worth mentioning that this guideline highlights the harm reduction and smoking cessation potential of e-cigarettes in the section on smoking cessation assistance, particularly emphasizing the importance of informing doctors about them. The hope is that doctors can better understand e-cigarettes.

 

There is mounting evidence that shows the significant effectiveness of e-cigarettes as a tool for quitting smoking. A comprehensive review of studies conducted by the Cochrane Collaboration, an international organization of evidence-based medical professionals, in 2021 shows that e-cigarettes have a quit-smoking effect, with a success rate twice that of nicotine replacement therapy and nicotine-free e-cigarettes.

 

Source: Southern News Net.

 

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Special Report|FDA Revises Device Name in Glas Vape Authorization; Company Signals Optimism on Menthol, Flavored Pods
Special Report|FDA Revises Device Name in Glas Vape Authorization; Company Signals Optimism on Menthol, Flavored Pods
The FDA updated public records on the PMTA authorization of a Glas vape product, renaming “Glas G Device” to “Glas G² Device” and releasing the order letter detailing scientific review and marketing restrictions. Company disclosures suggest the platform may include age-verification technology. If confirmed, Glas G² could be the first vape with device-level age verification to receive an FDA MGO. Glas executives also said menthol and other flavored pods could gain authorization in the future.
Special Report
Mar.14
New York Proposal to Tax Nicotine Pouches at 75% Draws Opposition
New York Proposal to Tax Nicotine Pouches at 75% Draws Opposition
A proposal by New York Governor Kathy Hochul to impose a steep tax on nicotine pouches has drawn opposition from law-enforcement officials and business groups, who say it could expand the state’s illicit tobacco market. The measure was included in Hochul’s preliminary two-year USD 260 billion budget plan and would treat nicotine pouches like other tobacco products.
Mar.17 by 2FIRSTS.ai
Tennessee’s “Tobacco Product Retail Licensing Act” Would Require New Licenses for Tobacco and Vapes
Tennessee’s “Tobacco Product Retail Licensing Act” Would Require New Licenses for Tobacco and Vapes
A newly introduced Tennessee bill, S.B. 2086, would create a statewide tobacco product retail licensing system, move oversight to the Tennessee Alcohol Commission, and impose fees and escalating penalties. The proposal also requires all tobacco product sales to occur as in-person, over-the-counter transactions at licensed locations—effectively banning direct-to-consumer shipping of cigars and potentially restricting curbside or phone-order pickup models.
Jan.28 by 2FIRSTS.ai
Product | Lost Vape launches “4D portable shisha” device with 3,800mAh battery and up to 80W output
Product | Lost Vape launches “4D portable shisha” device with 3,800mAh battery and up to 80W output
E-cigarette brand Lost Vape has recently listed its open-system DTL device, the ASTARA, on its official website. The company markets the product as “The First 4D Portable Shisha Experience,” highlighting a 360-degree display and audio features. The ASTARA has also appeared on some online sales channels in markets including the UK and Germany.
Feb.03 by 2FIRSTS.ai
Product | Claiming a “first multi-beverage vaporizer” with refillable juice/cocktail water chamber, PEAKBAR launches new device in the U.S.
Product | Claiming a “first multi-beverage vaporizer” with refillable juice/cocktail water chamber, PEAKBAR launches new device in the U.S.
PEAKBAR’s new H2O 40K has begun selling through U.S. online retailers including Vape Sourcing. Marketed as the “world’s first multi-beverage vaporizer,” the device is promoted as allowing users to add liquids such as juice and cocktails into a water chamber for pairing. Publicly listed specifications include 20 ml of e-liquid, a rated 40,000 puffs, 0.5% nicotine, a 1,000 mAh rechargeable battery, and two power modes at 22W and 12W.
Jan.22 by 2FIRSTS.ai
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
During the “Toxicological Profile” session at FDA’s Feb 10 PMTA roundtable, officials outlined the carcinogenicity tiering system and Excess Lifetime Cancer Risk (ELCR) framework used in ENDS reviews under the APPH standard. Small manufacturers questioned database transparency, exposure assumptions, and the existence of clear compliance benchmarks. FDA reiterated toxicological risk is assessed case by case within a broader population-level determination.
Feb.11